CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
REVENUES:
REVENUES	$ 49,521,923	$ 47,818,452
COSTS AND EXPENSES:
Cost of product sales	38,578,098	34,495,802
Research and development expenses	7,067,852	12,487,424
Selling, general and administrative expenses	24,277,834	24,840,611
Impairment, restructuring, severance and related costs	3,236,186	7,047,779
TOTAL COSTS AND EXPENSES	73,159,970	78,871,616
LOSS FROM OPERATIONS	(23,638,047)	(31,053,164)
OTHER INCOME (EXPENSE):
Interest (expense)/ income, net	(2,812,772)	(2,912,415)
Other income	3,194,567	0
LOSS BEFORE INCOME TAXES BENEFIT	(23,256,252)	(33,965,579)
Income tax (expense)/benefit	(34,405)	62,050
NET LOSS	$ (23,290,657)	$ (33,903,529)
Basic loss per share (in dollars per share)	$ (0.72)	$ (1.4)
Diluted loss per share (in dollars per share)	$ (0.72)	$ (1.4)
Weighted average number of shares outstanding, basic (in shares)	32,269,147	24,299,465
Weighted average number of shares outstanding, diluted (in shares)	32,269,147	24,299,465
Net Product Sales [Member]
REVENUES:
REVENUES	$ 47,091,673	$ 34,737,444
R&D Revenue [Member]
REVENUES:
REVENUES	112,986	1,159,381
Government Grant Income [Member]
REVENUES:
REVENUES	1,182,023	10,891,726
License and Royalty Revenue [Member]
REVENUES:
REVENUES	$ 1,135,241	$ 1,029,901